AWMDMG
DMK

Austin W. Marxe & David M. Greenhouse’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,500
Closed -$3.34M – 145
2014
Q1 		$3.34M Hold
7,500
– – 0.37% 75
2013
Q4 		$3.35M Buy
+7,500
New +$3.29M 0.36% 74

Other funds holding DMK

GP
Grow Partners San Diego, California $4.81M AUM 7.86% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's DMK Position: Q2 2014 in Review

Austin W. Marxe & David M. Greenhouse sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2014, closing a stake of 7,500 shares — an estimated $3.34M sold.

Austin W. Marxe & David M. Greenhouse first reported a position in DMK in Q4 2013 and held it in 2 quarters. The position peaked at $3.35M in Q4 2013. 20 funds tracked by Wall St. Rank hold DMK as of Q2 2014.

  • Austin W. Marxe & David M. Greenhouse reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2014 after selling out during the quarter.
  • Austin W. Marxe & David M. Greenhouse sold 7,500 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2014, an estimated $3.34M.
  • Austin W. Marxe & David M. Greenhouse first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2013 and held it in 2 quarters.
  • Austin W. Marxe & David M. Greenhouse's DMK Pharmaceuticals Corporation Common Stock position peaked at $3.35M in Q4 2013.
  • 20 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q2 2014, filed 8 Aug 2014.